TP53 and neoplasm: p14ARF, on the other hand, by accumulating evidence is suggested to act as a tumour suppressor by neutralising MDM2-mediated degradation of p53 (Pomerantz et al, 1998; Stott et al, 1998; Zhang et al, 1998).